Cascade Corporation | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (31)

View All

Latest Posts

About This Stock More About This Stock
Cascadian Therapeutics Prices $82.5 Million Concurrent Offerings Of Common Stock And Preferred Stock
Article By: NASDAQ GlobeNewswire
Tuesday, January 24, 2017 9:19 AM EDT
Cascadian Therapeutics, Inc., today announced the pricing of the previously announced concurrent but separate underwritten offerings of 23,182,000 shares of its common stock at a price to the public of $3.30 per share.
In this article: CASC
Read
Is Cascadian Therapeutics Inc (CASC) A Good Stock To Buy?
Article By: Insider Monkey
Sunday, December 18, 2016 7:59 PM EDT
In this article, we take a closer look at Cascadian Therapeutics Inc. from the perspective of successful hedge funds. Is Cascadian Therapeutics Inc. a superb investment today? Hedge funds are definitely reducing their bets on the stock.
In this article: CASC, DQ, VRS, FFKT, ADAP
Read
Cascadian Therapeutics Announces Proposal For Reverse Stock Split
Article By: NASDAQ GlobeNewswire
Tuesday, October 4, 2016 10:16 PM EDT
Cascadian Therapeutics, today announced that its board of directors has approved a plan for a reverse split of the Company’s common stock to increase its share price and reduce the number of authorized and outstanding shares.
In this article: CASC
Read
All Posts

Latest Tweets for $CASC

No tweets yet!

PARTNER HEADLINES